2022 Revenues ($USD) : $3,917,343,585
2022 Revenues (foreign currencies) : RMB25,270,000,000
2022 R&D spend : $423,203,324
2022 Number of Employees : 14,684
Fiscal Year End : 12/31/2021
Company CEO : Li Xiting, chair

Founded in 1991, Shenzhen, China–based Mindray has three core businesses: Patient Monitoring and Life Support, Medical Imaging, and In-Vitro Diagnostics. It has 40 international subsidiaries worldwide. Over the years, it’s expanded its capabilities through the 2008 acquisition of Datascope’s patient monitoring business and the 2013 acquisition of ultrasound tech company Zonare Medical Systems. Zonare’s software-based Zone Sonography technology (ZST) is the basis of Mindray’s Living Technology, a constantly evolving architecture to meet clinicians’ changing imaging needs. –CN